Skip to main content
. 2025 Apr 29;13(5):1079. doi: 10.3390/biomedicines13051079
POD Postoperative day
BP Bursting pressure
IBDs Inflammatory bowel diseases
INFL Infliximab
VDLZ Vedolizumab
USTK Ustekinumab